{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:50:49Z","timestamp":1790484649156,"version":"4.1.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.8392","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T15:07:33Z","timestamp":1650553653000},"page":"e228392","source":"Crossref","is-referenced-by-count":126,"title":["Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment"],"prefix":"10.1001","volume":"5","author":[{"given":"Yan","family":"Hu","sequence":"first","affiliation":[{"name":"C2N Diagnostics, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher M.","family":"Kirmess","sequence":"additional","affiliation":[{"name":"C2N Diagnostics, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Meyer","sequence":"additional","affiliation":[{"name":"C2N Diagnostics, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil D.","family":"Rabinovici","sequence":"additional","affiliation":[{"name":"Departments of Neurology, Radiology & Biomedical Imaging, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine","family":"Gatsonis","sequence":"additional","affiliation":[{"name":"Center for Statistical Sciences, Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A.","family":"Siegel","sequence":"additional","affiliation":[{"name":"Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Whitmer","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, University of California, Davis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Apgar","sequence":"additional","affiliation":[{"name":"American College of Radiology, Reston, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Hanna","sequence":"additional","affiliation":[{"name":"Center for Statistical Sciences, Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Kanekiyo","sequence":"additional","affiliation":[{"name":"Eisai, Woodcliff Lake, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Kaplow","sequence":"additional","affiliation":[{"name":"Eisai, Woodcliff Lake, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Koyama","sequence":"additional","affiliation":[{"name":"Eisai, Woodcliff Lake, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Verbel","sequence":"additional","affiliation":[{"name":"Eisai, Woodcliff Lake, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary S.","family":"Holubasch","sequence":"additional","affiliation":[{"name":"C2N Diagnostics, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S.","family":"Knapik","sequence":"additional","affiliation":[{"name":"C2N Diagnostics, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Connor","sequence":"additional","affiliation":[{"name":"ConfluenceStat, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Contois","sequence":"additional","affiliation":[{"name":"C2N Diagnostics, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin N.","family":"Jackson","sequence":"additional","affiliation":[{"name":"C2N Diagnostics, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Harpstrite","sequence":"additional","affiliation":[{"name":"C2N Diagnostics, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Bateman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip B.","family":"Verghese","sequence":"additional","affiliation":[{"name":"C2N Diagnostics, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Fogelman","sequence":"additional","affiliation":[{"name":"C2N Diagnostics, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel B.","family":"Braunstein","sequence":"additional","affiliation":[{"name":"C2N Diagnostics, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Yarasheski","sequence":"additional","affiliation":[{"name":"C2N Diagnostics, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"West","sequence":"additional","affiliation":[{"name":"C2N Diagnostics, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"issue":"3","key":"zoi220255r1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/alz.v16.3","article-title":"2020 Alzheimer\u2019s disease facts and figures.","volume":"16","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"12","key":"zoi220255r2","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/alz.v17.12","article-title":"Population estimate of people with clinical Alzheimer\u2019s disease and mild cognitive impairment in the United States (2020-2060).","volume":"17","author":"Rajan","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"5594","key":"zoi220255r3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure.","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"issue":"3","key":"zoi220255r4","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1212\/WNL.49.3_Suppl_3.S7","article-title":"Clinical assessment of Alzheimer\u2019s disease.","volume":"49","author":"Morris","year":"1997","journal-title":"Neurology"},{"issue":"5580","key":"zoi220255r5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics.","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"2","key":"zoi220255r6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies.","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"issue":"9","key":"zoi220255r7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics.","volume":"10","author":"Karran","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"zoi220255r8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2174\/156720506779025189","article-title":"Filling the gaps in the A\u00df cascade hypothesis of Alzheimer\u2019s disease.","volume":"3","author":"Golde","year":"2006","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"zoi220255r9","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: a genetic perspective.","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"issue":"6","key":"zoi220255r10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nn.4018","article-title":"Three dimensions of the amyloid hypothesis: time, space and \u2018wingmen\u2019.","volume":"18","author":"Musiek","year":"2015","journal-title":"Nat Neurosci"},{"issue":"4","key":"zoi220255r11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","article-title":"Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.","volume":"71","author":"Beach","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"zoi220255r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionps.2019.100005","article-title":"Diagnostic biomarkers of Alzheimer\u2019s disease: a state-of-the-art review.","volume":"1","author":"Khoury","year":"2019","journal-title":"Biomarkers Neuropsychiatry"},{"issue":"13","key":"zoi220255r13","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2019.2000","article-title":"Association of amyloid positron emission tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia.","volume":"321","author":"Rabinovici","year":"2019","journal-title":"JAMA"},{"issue":"17","key":"zoi220255r14","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u00df-amyloid 42\/40 predicts current and future brain amyloidosis.","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"issue":"8","key":"zoi220255r15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","article-title":"Amyloid \u00df concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis.","volume":"13","author":"Ovod","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"7691","key":"zoi220255r16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u00df biomarkers for Alzheimer\u2019s disease.","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"issue":"11","key":"zoi220255r17","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","article-title":"Head-to-head comparison of 8 plasma amyloid-\u00df 42\/40 assays in Alzheimer disease.","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol"},{"issue":"1","key":"zoi220255r18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-021-00451-6","article-title":"A blood-based diagnostic test incorporating plasma A\u00df42\/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis.","volume":"16","author":"West","year":"2021","journal-title":"Mol Neurodegener"},{"key":"zoi220255r19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cca.2021.05.011","article-title":"The PrecivityAD test: accurate and reliable LC-MS\/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis.","volume":"519","author":"Kirmess","year":"2021","journal-title":"Clin Chim Acta"},{"issue":"2","key":"zoi220255r20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.14283\/jpad.2021.4","article-title":"Amyloid and APOE status of screened subjects in the Elenbecestat MissionAD phase 3 program.","volume":"8","author":"Roberts","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"issue":"2","key":"zoi220255r21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2018.09.001","article-title":"Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer\u2019s disease neuropathology.","volume":"15","author":"La Joie","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"5","key":"zoi220255r22","doi-asserted-by":"publisher","first-page":"e662","DOI":"10.1212\/WNL.0000000000011222","article-title":"Association of \u00df-amyloid level, clinical progression, and longitudinal cognitive change in normal older individuals.","volume":"96","author":"van der Kall","year":"2021","journal-title":"Neurology"},{"issue":"2","key":"zoi220255r23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/jamaneurol.2020.3780","article-title":"Association between apolipoprotein E e2 vs e4, age, and \u00df-amyloid in adults without cognitive impairment.","volume":"78","author":"Insel","year":"2021","journal-title":"JAMA Neurol"},{"key":"zoi220255r24","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12470","article-title":"Expected wait times for access to a disease-modifying Alzheimer\u2019s treatment in the United States.","author":"Mattke","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"3","key":"zoi220255r25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.parkreldis.2011.10.013","article-title":"Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials.","volume":"18","author":"Whitwell","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 7","key":"zoi220255r26","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1093\/brain\/awv112","article-title":"Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.","volume":"138","author":"Villeneuve","year":"2015","journal-title":"Brain"},{"issue":"1","key":"zoi220255r27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13195-020-00587-5","article-title":"Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer\u2019s disease.","volume":"12","author":"Amadoru","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"zoi220255r28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","article-title":"Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u00df plaques: a prospective cohort study.","volume":"11","author":"Clark","year":"2012","journal-title":"Lancet Neurol"},{"issue":"4","key":"zoi220255r29","doi-asserted-by":"publisher","first-page":"e619","DOI":"10.1212\/WNL.0000000000011214","article-title":"Defining the lowest threshold for amyloid-PET to predict future cognitive decline and amyloid accumulation.","volume":"96","author":"Farrell","year":"2021","journal-title":"Neurology"},{"issue":"6","key":"zoi220255r30","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jalz.2019.02.005","article-title":"Comparison of 18F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL approaches: validation against histopathology.","volume":"15","author":"Dor\u00e9","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"12","key":"zoi220255r31","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.jalz.2018.06.1353","article-title":"Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale.","volume":"14","author":"Navitsky","year":"2018","journal-title":"Alzheimers Dement"},{"key":"zoi220255r32","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/geroni\/igab046.3585","article-title":"Early clinical utility data of a blood biomarker test in the evaluation of patients with cognitive impairment.","volume":"5","author":"Monane","year":"2021","journal-title":"Innov Aging"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2791438\/hu_2022_oi_220255_1649955293.88817.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T15:07:36Z","timestamp":1650553656000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2791438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.8392","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,21]]}}}